Nektar Therapeutics
NKTR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $801,568 | $364,016 | $143,428 | $195,055 |
| - Cash | $41,032 | $42,988 | $38,894 | $44,252 |
| + Debt | $91,915 | $96,156 | $100,337 | $102,564 |
| Enterprise Value | $852,451 | $417,184 | $204,871 | $253,367 |
| Revenue | $11,790 | $11,175 | $10,460 | $29,175 |
| % Growth | 5.5% | 6.8% | -64.1% | – |
| Gross Profit | $11,790 | $11,175 | $10,460 | $21,198 |
| % Margin | 100% | 100% | 100% | 72.7% |
| EBITDA | -$29,312 | -$33,787 | -$40,969 | $17,487 |
| % Margin | -248.6% | -302.3% | -391.7% | 59.9% |
| Net Income | -$35,522 | -$41,593 | -$50,882 | $7,261 |
| % Margin | -301.3% | -372.2% | -486.4% | 24.9% |
| EPS Diluted | -1.87 | -2.95 | -3.62 | 0.51 |
| % Growth | 36.6% | 18.5% | -809.8% | – |
| Operating Cash Flow | -$48,761 | -$45,738 | -$49,053 | -$46,187 |
| Capital Expenditures | -$114 | -$37 | -$2 | -$459 |
| Free Cash Flow | -$48,875 | -$45,775 | -$49,055 | -$46,646 |